FDA approves generic version of Cordarone for arrhythmia

ROCKVILLE, Md. The Food and Drug Administration has approved Apotex’s amiodarone hydrochloride tablets, FDA records show.

The tablets, available in 200 mg dosages, are a generic version of Wyeth’s arrhythmia drug Cordarone. A number of other companies, including Barr Labs, Sandoz, Taro and Teva also sell generic versions, and an injected version is available as well.

FDA records indicate an approval date of Nov. 6.